Medikit Co.,Ltd. announces an Equity Buyback for 144,000 shares, representing 0.86% for ¥400 million.
December 16, 2021 at 01:30 am EST
Share
Medikit Co.,Ltd. (JASDAQ:7749) announces a share repurchase program. Under the program, the company will repurchase up to 144,000 shares, representing 0.86% of its issued share capital (excluding treasury stock), for a total purchase price of ¥400 million. The purpose of the program is to implement agile capital policies, improve capital efficiency, and return profits to shareholders in response to changes in the business environment. The program will continue through June 30, 2022. As of September 30, 2021, the company had 16,805,280 issued shares (excluding treasury stock) and 2,074,720 treasury shares.
MEDIKIT CO., LTD. is a Japan-based company involved in the development, manufacture and sale of medical equipment. Its major products consist of artificial diagnostic equipment, which includes indwelling needles that are used for artificial dialysis purposes; indwelling venous needles (anesthesia type), which are used for blood and fluid transfusion purposes, and angiography equipment, which includes introducers and angiographic catheters.